A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
Applications | FC |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Applications | FC |
Reactivities | Human |
Recombinant Anti-CD52 (Clone Campath-1H)
Applications | CT, ELISA, FC, IHC, WB |
Reactivities | Human, Monkey |
SARS-CoV-2 N protein monoclonal antibody
Applications | ELISA, ICC, WB |
Reactivities | SARS-CoV-2 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
CNY 14,213.00
4周
Chimaeric Human IgE anti Nitrophenyl-hapten (NP) human monoclonal antibody, clone JW8/1, Supernatant
Applications | ELISA |
CNY 6,881.00
6周
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
Applications | Bl, FC, IF, IHC, WB |
Reactivities | Human, Monkey |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
CD47 monoclonal antibody (magrolimab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
SARS-CoV-2 Spike protein RBD monoclonal antibody
Applications | ELISA |
Reactivities | SARS-CoV-2 |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Recombinant Anti-EGFR (Clone Matuzumab)
Applications | Bl, ELISA, FC, IF, WB |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |